(
412
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task Force
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
-
A systematic review and meta-analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report
-
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
-
A systematic review and meta-analysis on nutritional and dietary interventions for the treatment of acute respiratory infection in pediatric patients: An EAACI taskforce
-
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic study
-
Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paper
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic procedures
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
-
Biologicals in atopic disease in pregnancy: An EAACI position paper
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
-
Comparison of two different pollen season definitions based on 10 years of birch and grass pollen data from two distant central European cities: An EAACI Task Force report
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
-
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants – An EAACI Position Paper
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
-
Diagnosis and management of food allergy-induced constipation in young children—An EAACI position paper
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
-
EAACI Position paper on the standardization of nasal allergen challenges
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance
-
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
-
Endotyping in Chronic Rhinosinusitis—An EAACI Task Force Report
-
Eosinophils – from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion
-
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
-
Feeding difficulties in children with food allergies: An EAACI Task Force Report
-
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper
-
Food allergy – A holistic approach to dietary management. A joint EAACI Research & Outreach Committee and INDANA review
-
Food processing and occupational respiratory allergy- An EAACI position paper
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review – An EAACI position paper
-
Global assessment of the knowledge and confidence in managing allergic disorders among primary care pediatricians across Europe: An EAACI task force report
-
Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper
-
Hypersensitivity reactions to biological agents: An EAACI position paper
-
Hypersensitivity reactions to chemotherapy: an EAACI position paper
-
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan – An EAACI position paper
-
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
-
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
-
Omics technologies in allergy and asthma research: An EAACI position paper
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
-
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas – An EAACI Task Force Report
-
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disorders
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper
-
Role of dietary fiber in promoting immune health – An EAACI position paper
-
Skin microdialysis: methods, applications and future opportunities – an EAACI position paper
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
-
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
-
Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper
-
The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper
-
The development of birch pollen seasons over 30 years in Munich, Germany – An EAACI task force report
-
The influence of lifestyle and environmental factors on host resilience through a homeostatic skin microbiota: An EAACI Task Force Report
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statement
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper
-
The role of mobile health technologies in allergy care: An EAACI position paper
-
Toward clinically applicable biomarkers for asthma: An EAACI position paper
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams – an EAACI position paper
-
Ultra-processed foods, allergy outcomes and underlying mechanisms in children: An EAACI task force report
Show more Position Papers (79)Show Less-
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
EAACI & AAAAI joint symposium – Environmental Disparities in Underserved Populations
-
EAACI & AAAAI joint symposium: hot topics in drug hypersensitivity
-
EAACI & ACAAI joint symposium: Current Trends in Allergy
-
EAACI & ACAAI joint symposium: pediatric asthma-state of the art in 2022
-
EAACI & APAAACI joint symposium: Allergic and immunological diseases in Asia
-
EAACI & APAPARI joint symposium: Novel lessons in the diagnosis and prevention of allergies
-
EAACI & GARD joint symposium: GARD priorities in 2022
-
EAACI & JSA joint symposium: new aspects of allergic diseases in mucosal tissue
-
EAACI & KAAACI joint symposium
-
EAACI & KAAACI joint symposium: navigating the universe of eosinophilic inflammation in asthma
-
EAACI & NIAID/NIH joint symposium: advances on the role of the microbiome in allergic diseases
-
EAACI & SLAAI joint symposium: The future of allergology from a global perspective: collaboration is the key toimprove our knowledge
-
EAACI & SLAAI joint symposium: climate change, global warming, pollution and allergic diseases: reality in Latin America
-
EAACI & WAO joint symposium: World Allergy Forum severe food allergy update
-
EAACI & WAO joint symposium: World Allergy Forum, Mast cells – biology and disease
-
EAACI Global Stage: East vs West
-
EAACI Guideline on NAR: does it need to be updated?
-
EAACI Journals Highlights
-
EAACI Journals Highlights
-
GINA Guidelines Update
-
RHINA: Towards CRS guidelines
-
RHINA: What can we learn from the asthma guidelines
-
EAACI & ERS joint symposium: new ERS clinical guidelines on diagnosis of asthma in school children
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
EAACI Food allergy guidelines launched
-
EAACI Guidelines on Diagnosis of Food Allergy: what is new?
-
EAACI Guidelines on environmental health
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
Show more Event Resources (27)Show Less-
-
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
-
EAACI guidelines: Anaphylaxis (2021 update)
-
The international WAO/ EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
-
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)
-
EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
-
EAACI Biologicals Guidelines – Recommendations for severe asthma
-
EAACI Biologicals Guidelines – Treatment with biologicals for severe chronic rhinosinusitis with nasal polyps
-
EAACI Biologicals Guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis
-
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
-
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy
-
EAACI Guidelines on the Management of IgE-Mediated Food Allergy
-
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
-
EAACI guidelines on allergen immunotherapy: Prevention of allergy
-
EAACI guidelines on environmental science in allergic diseases and asthma
-
EAACI guidelines on the diagnosis of IgE-mediated food allergy
Show more Guidelines (15)Show Less-
-
EAACI Comparative and Veterinary Allergology (CVA) Working Group educational Webinars
-
EAACI GoGreen Webinar: How to go green in laboratories
-
EAACI GoGreen webinar: How to go green in clinical care – real world examples
-
EAACI GoGreen webinar: How to go green in hospitals
-
EAACI GoGreen webinar: How to go green in telemedicine
-
EAACI GoGreen webinar: How to go green via Inhalers
-
EAACI Symposium at the National Conference of the Romanian Society of Allergology: Immune modulation in Allergic Diseases
-
EAACI Webinar on Eosinophilic Esophagitis
-
EAACI Webinar on Pediatric Asthma
-
FOCIS 2022 – EAACI Digital Symposium: Effects of microbiota on immune response in allergy prevention and therapy
-
Granulocytes and Mast Cells in AllergoOncology—Bridging Allergy to Cancer: An EAACI Position Paper
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
-
EAACI Guidelines on the diagnosis of IgE-mediated food allergy: What’s new?
Show more Webinars (11)Show Less-
-
EAACI position paper on the diagnosis and therapeutic management of allergic bronchopulmonary aspergillosis (ABPA)
-
EAACI primary care paediatricians allergy educational needs Task Force
-
Exercise and physical activity for asthma management: an EAACI task force position paper
-
How EAACI recommendations on ocular allergy diagnosis and treatment are applied in real life clinical practice: an international multidisciplinary survey
-
Updated guidelines on the risk assessment and methodology of skin tests for the investigation of drug allergy
Show more Task Forces (3)Show Less-
-
COVID-19 Pandemic and allergen immunotherapy – an EAACI survey
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold – an ARIA- EAACI – GA2LEN consensus
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section
Show more Covid-19 (3)Show Less-
-
Anaphylaxis Awareness Day: A Milestone for EAACI
-
EP1 – EAACI Congress 2024: Revolutionising patient care through the power of data science.
-
EP2 – Countdown to EAACI Congress 2024: Inside the NAS Committee Meeting
-
EP3 – EAACI Congress 2024: A Sneak Peek into the Plenaries and Symposiums
-
EP4 – EAACI Congress 2024: Discover the upcoming Immunology Update Course – 31 May 2024
Show more Podcasts (3)Show Less-
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paper
-
ERS/EAACI statement on adherence to international adult asthma guidelines
-
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
Show more Consensus Documents (2)Show Less-
Website
Collapse
-
A Pendemic? A review of the prescription of adrenaline auto-injectors among new referrals to paediatric allergy clinics according to the updated European Academy of Allergy and Clinical Immunology guidelines (2021)
-
A consensus protocol for the basophil activation test – EAACI task force report
-
An EAACI Task Force Report: Global assessment of the knowledge and confidence in managing allergic disorders amongst primary care paediatricians across Europe
-
Anaphylaxis Latin American Guidelines
-
Asthma remission in EGPA patients: applicability and concordance of the main international guidelines
-
Chronic hand eczema – updated guidelines
-
Decoding allergic patient’s monocytic cells and their value in AllergoOncology with MacTooL: an EAACI scoping review
-
Developing relevant and applicable CRS guidelines in the era of biologics
-
EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease
-
EAACI & AAAAI Joint Symposium – Atopic Dermatitis 2025: Novel Pathophysiology & Treatment Insights
-
EAACI & ACAAI Joint Symposium : Unified Airway Disease
-
EAACI & APAAACI Joint Symposium : Recent Developments in Environmental Issues, Allergic Diseases, and Vaccination in Asia Pacific
-
EAACI & APAAACI Joint Symposium : Allergic and immunological diseases in Asia: current concepts and innovations : from trained immunity, microbiome and ECRS
-
EAACI & APAPARI Joint Symposium : Emerging concepts in the management of food allergies
-
EAACI & APAPARI joint symposium – Novel approaches to the management of fish allergy
-
EAACI & CIA JOINT SYMPOSIUM : Shaping the Future of Allergy Research: Showcasing New Leaders in the Collegium Internationale Allergologicum (CIA)
-
EAACI & IPCRG Joint Symposium : Rhinitis Right Care: how to gain interest, confidence and competence in good quality primary care
-
EAACI & JSA Joint Symposium : New Insights into the Mechanism and Treatment Strategies for Unified Airway Disease
-
EAACI & JSA joint symposium : Current topics of allergic and eosinophilic diseases
-
EAACI & KAAACI Joint Symposium : New Horizons of Allergy & Eosinophilic diseases
-
EAACI & KAAACI Joint Symposium : New horizons toward controlling allergy and allergens
-
EAACI & NIAID Joint Symposium : Harnessing the Potential of Endotyping Data to Predict Clinical Outcomes in Allergic Disease
-
EAACI & SLAAI Joint Symposium : Improving patient care in low-income region with the best science data
-
EAACI & SLAAI Joint Symposium : Air pollution In Latin America
-
EAACI & WAO Joint Symposium – Improved approaches in food allergy
-
EAACI & WAO Joint Symposium : World Allergy Forum – Is the Burden of Chronic Cough Underappreciated in Allergy Practice?
-
EAACI & ACAAI Joint Symposium : Updates on Strategies to Address Inflammation in Allergy-Immunology Practice
-
EAACI & APAPARI Joint Symposium : New lessons of pediatric allergy from around the world
-
EAACI & IPCRG Joint Symposium : Improving the Delivery of Person-centred asthma care in global primary care
-
EAACI Course on immunology update : selected topics in basic and translational immunology
-
EAACI Course on immunology update : selected topics in basic and translational immunology
-
EAACI Enlightening Talks – 2
-
EAACI Enlightening Talks – 3
-
EAACI Enlightening Talks-1
-
EAACI Family Reception
-
EAACI General Assembly
-
EAACI Guidelines: key highlights
-
EAACI Highlight Plenary session Focus on Angioedema and Mast Cell Diseases
-
EAACI Highlight Session
-
EAACI Journals
-
EAACI Members Experience video
-
EAACI Portuguese meeting – Doença Alérgica Grave em Idade Pediatrica
-
EAACI President 2024-2026 address
-
EAACI Spanish meeting – Inmunoterapia a alimentos
-
EAACI nomenclature for allergy and asthma
-
EAACI position paper about basophil activation test in immediate drug hypersensitivity
-
Estructura y funcionamiento de la EAACI
-
Estructura y funcionamiento de la EAACI
-
Evaluation of the concordance of definitions of Asthma Remission according to international guidelines in a cohort of patients treated with monoclonal antibodies for severe asthma
-
Food Allergy: New Guidelines for Diagnosis and Management
-
From Vision to Legacy: The Story of EAACI and Its Impact on Allergy and Immunology
-
Global Initiative for Asthma (GINA) Guidelines
-
Handover to the Scottish embassador for EAACI 2025
-
Harmonizing clinical outcomes in food allergen immunotherapy: COFAITH EAACI Taskforce
-
Highlights of EAACI Guidelines: Latest Developments and Clinical Applications
-
Highlights of EAACI Task Forces: Bridging Innovation and Clinical Practice
-
How should we be putting the new food allergy diagnosis guidelines into practice?
-
Impact of the new UK guidelines on the emergency management of anaphylaxis at two hospitals
-
Inaugural address by EAACI President
-
Infant feeding and allergy prevention guidelines reduce IgE-mediated egg and peanut allergies prevalence – a cohort comparison study
-
Introduction of the new EAACI President
-
Nomenclature – EAACI highlights
-
Oportunidades educacionales en la EAACI
-
Oportunidades educacionales en la EAACI
-
RHINA : What can we learn from the asthma guidelines
-
RHINA :Towards CRS guidelines
-
Should we standardize global guidelines for AD and Food Allergy prevention?
-
Sub-study from the EAACI allergy educational needs in Primary Care Paediatricians to gauge association of GDP impact on differences of allergy diagnosis and treatment healthcare
-
Th2 Biologics in primary atopic disorders: the ATO-PID EAACI task force
-
The Prevalence of NSAID‐exacerbated Respiratory Disease in one allergy center from China: Diagnosis adhering to EAACI Position Paper
-
Translational tools (adaptive trial design, end points in clinical trials and registries) the EAACI Highlights
-
Update on early life nutrition guidelines and allergy prevention
-
Updates in urticaria guidelines
-
Welcome address from the EAACI Pediatric Board Chair
-
Welcome address from the EAACI President
-
Welcome to the EAACI presidential symposium
-
Year in Review EAACI Journals
-
Drug Allergy: Implementing the Latest EAACI Guidelines in Clinical Practice
-
EAACI Food allergy guidelines launched
-
EAACI Guidelines on IgE-mediated food allergy and beyond
-
EAACI meet and greet the EAACI Leadership
-
EAACI meet and greet the EAACI Leadership
-
New EAACI Food Allergy Guidelines
-
The BAT as a recommended test for food allergy diagnosis in the EAACI Food Allergy Guidelines
Show more Sessions (82)Show Less-
-
Abstract Submission Guidelines
-
Abstract Submission Guidelines
-
Chair Interface Guidelines
-
DGAKI / EAACI Joint Session
-
EAACI App
-
EAACI App
-
EAACI Campus & Registration Area
-
EAACI Congress 2025
-
EAACI Congress 2024
-
EAACI Congress 2023
-
EAACI Hybrid Congress 2022
-
EAACI Hybrid Congress 2021
-
EAACI Digital Congress 2020
-
EAACI Congress 2019
-
Back to the images on EAACI Congress 2019
-
A. Lauerma, EAACI Congress 2017 Chair, Finland
-
EAACI Founder Sponsors
-
EAACI Media Library
-
EAACI Media and Embargo Policy
-
EAACI Media and Embargo Policy
-
EAACI Membership
-
EAACI Scholarships
-
EAACI Scholarships
-
EAACI Scholarships
-
EAACI Scholarships
-
EAACI TV
-
EAACI TV
-
EAACI UEMS Exam
-
EAACI UEMS Exam
-
EAACI Virtual Congress Hubs
-
EAACI Virtual Congress Hubs
-
Faculty Guidelines
-
Faculty Guidelines
-
Flash Talk Presenter Guidelines
-
Flash Talk Presenters Guidelines
-
General Speaker Guidelines
-
OAS, OAS-CT and PiS Presenters Guidelines
-
Oral Abstract Presenter Guidelines
-
Past EAACI Congresses Statistics
-
Poster Presenter Guidelines
-
Poster Presenter Guidelines
-
Poster Presenter Guidelines
-
Poster Presenter Guidelines
-
Poster Presenter Guidelines
-
Poster Presenters Guidelines
-
Poster Speaker Guidelines
-
Presenter & Speaker Guidelines
-
Pro & Con Speaker Guidelines
-
Speaker Guidelines
-
Speaker Guidelines
-
Speaker Guidelines
-
Speaker Guidelines
-
Speaker Guidelines
-
Speakers and Abstract Presenters Guidelines
Show more Annual Congress (52)Show Less-
-
Conference of the Parties 27: EAACI Session
-
EAACI Congress 2024 will be held in Valencia
-
Cover the Latest Developments in Allergy and Asthma at the EAACI Congress 2024 in Valencia, Spain
-
Discover our EAACI Knowledge Hub AIT Module
-
Discover the latest edition of the EAACI Review
-
EAACI Celebrates International Day of Clean Air for Blue Skies
-
EAACI Launches Second Phase of Groundbreaking Allergy Management Project
-
EAACI Launches the Knowledge Hub
-
EAACI President María Torres Speaks on Drug Allergies at CAC Porto Conference
-
EAACI Presidential message – New Year’s Greetings
-
EAACI Supplemental Elections 2022-2024
-
EAACI Wants to Hear From You!
-
EAACI launches three initiatives to support our Ukrainian colleagues
-
EAACI stands in solidarity with Valencia and all flood-affected regions in Spain
-
EAACI supports our Ukrainian colleagues – Opportunities for Ukrainian researchers
-
Explore our EAACI Knowledge Hub Module: Towards precise management of drug allergy
-
Introducing The New EAACI Review 06: Reflecting on 2023 and Looking Forward to a Promising 2024!
-
Introducing The New EAACI Review 07: Committed to your health
-
Introducing The New EAACI Review 08: Committed to your health
-
Introducing The New EAACI Review: A Gateway to Cutting-Edge Research in Allergy and Clinical Immunology
-
Invest in Our Planet: EAACI in Support of Sustainable Health
-
Join the EAACI session at COP27
-
Join us at the EAACI GoGreen Webinar series!
-
New Clinical Guidelines for the Diagnosis of Immediate-type Food Allergies are launched
-
New EAACI Paper: Immune-mediated disease caused by climate change-associated environmental hazards: mitigation and adaptation
-
No collaboration and partnership between EAACI and GA2LEN. No joint guideline(s)
-
Read the full EAACI MAUG Book 2.0 on the Knowledge Hub
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma Management
-
Take the survey by the EAACI Task Force: Improving Chronic Urticaria Management in Pediatrics – (ICUMP) Management (2)
-
EAACI Guidelines on the Diagnosis of IgE-mediated Food Allergy – public consultation
-
EAACI Unveils Groundbreaking Guidelines for IgE-Mediated Food Allergy Management
-
EAACI environmental guidelines – recommendations for public comment
Show more News (30)Show Less-
-
EAACI Anaphylaxis Awareness Day
-
EAACI Booth & Registration
-
EAACI Booth & Registration area
-
EAACI Certified Advanced Research Centres
-
EAACI Founder Sponsors
-
EAACI Founder Sponsors
-
EAACI Founder Sponsors
-
EAACI Founder Sponsors
-
EAACI Founder Sponsors
-
Speaker and OAS Presenters Guidelines
-
Speaker, OAS and FT Presenter guidelines
-
Speaker, OAS and FT Presenter guidelines
-
Speakers and Abstract Presenters Guidelines
-
Speakers and Abstract Presenters Guidelines
-
Speakers and Abstract Presenters Guidelines
Show more Focused Meetings (13)Show Less-
-
EAACI
-
EAACI – Board of Officers
-
EAACI – Election Process
-
EAACI – Eligibility
-
EAACI – Reimbursement & Benefits
-
EAACI – Sage HR Tool
-
EAACI – Standard Operating Procedures
-
EAACI – Timelines
-
EAACI – HQ Team
-
MC – EAACI Brand Guidelines & Resources
-
SCI – Guidelines
-
SCI – Guidelines & Manuscripts
-
EAACI – Guidelines & Policies
Show more Handbook (11)Show Less-
-
EAACI
-
EAACI Advanced Research Centre
-
EAACI Anaphylaxis Awareness Day
-
EAACI Annual Congress still at the forefront of innovation and progression
-
EAACI Centre of excellence
-
EAACI Certified Advanced Research Centres
-
EAACI Certified Advanced Research Centres
-
EAACI Certified Clinic & Research Centre
-
EAACI Certified Clinical Centre
-
EAACI Headquarters
-
Protected: EAACI Quality Centres
-
EAACI Sponsors
-
Important Onsite Industry Information @ EAACI 2024 Valencia
Show more Page (11)Show Less-
